{"id":"https://openalex.org/G8106077029","display_name":"Analysis of immune microenvironment-related germline variants in gliomas","description":"\u30b0\u30ea\u30aa\u30fc\u30de\u306f\u4e88\u5f8c\u4e0d\u826f\u306a\u8133\u816b\u760d\u3067\u3042\u308b\u3002\u8fd1\u5e74\u3001\u4f53\u7d30\u80de\u907a\u4f1d\u5b50\u5909\u7570\u306e\u89e3\u6790\u304c\u9032\u3093\u3067\u3044\u308b\u304c\u3001germline\uff08\u751f\u6b96\u7d30\u80de\u7cfb\u5217\uff09\u30d0\u30ea\u30a2\u30f3\u30c8\u306b\u3064\u3044\u3066\u306f\u4e0d\u660e\u306a\u70b9\u304c\u591a\u3044\u3002\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u514d\u75ab\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3092\u6c7a\u5b9a\u3059\u308b\u8981\u7d20\u3068\u3057\u3066\u3001\u816b\u760d\u306e\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u308b\u304c\u3001\u4f53\u5185\u306e\u5168\u7d30\u80de\u306b\u5b58\u5728\u3059\u308bgermline\u30d0\u30ea\u30a2\u30f3\u30c8\u306f\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u306b\u5f71\u97ff\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002\u3057\u304b\u3057\u3001germline\u30d0\u30ea\u30a2\u30f3\u30c8\u3068\u30b0\u30ea\u30aa\u30fc\u30de\u306e\u4e88\u5f8c\u3084\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u3068\u306e\u95a2\u9023\u306b\u3064\u3044\u3066\u306f\u672a\u3060\u4e0d\u660e\u3067\u3042\u308b\u3002\u672c\u7814\u7a76\u3067\u306f\u3001\u65b0\u898fgermline\u30d0\u30ea\u30a2\u30f3\u30c8\u3067\u3042\u308bPIK3R1 Met326Ile\u304c\u30b0\u30ea\u30aa\u30fc\u30de\u306e\u767a\u751f\u7387\u3001\u4e88\u5f8c\u3001\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u89e3\u6790\u3059\u308b\u3002","funder_award_id":"21K09100","funder":{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","doi":"https://doi.org/10.13039/501100001691"},"funded_outputs":["https://openalex.org/W3047415146","https://openalex.org/W3131033870","https://openalex.org/W3164346346","https://openalex.org/W3208757803","https://openalex.org/W4200015756","https://openalex.org/W4304481457","https://openalex.org/W4383899960","https://openalex.org/W4391280199"],"funded_outputs_count":8,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":4160000.0,"currency":"JPY","amount_usd":37578.53,"amount_usd_basis":"daily_rate","recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"Grant-in-Aid for Scientific Research (C)","start_date":"2021-04-01","end_date":"2024-03-31","start_year":2021,"end_year":2024,"landing_page_url":"https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-21K09100/","doi":null,"provenance":"kaken","lead_investigator":{"given_name":"Kenji","family_name":"Sugiu","orcid":null,"role_start":null,"affiliation":{"name":"Okayama University","country":"Japan","ids":[{"id":"https://nrid.nii.ac.jp/nrid/1000040325105","type":"nrid","asserted_by":"kaken"}]},"author":{"id":"https://openalex.org/A5066552893","display_name":"Kenji Sugiu","orcid":"https://orcid.org/0000-0001-9006-999X"},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G8106077029","primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9609,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0261,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0017,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.969},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.997},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.973},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.623},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.651},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.715},{"id":"https://openalex.org/keywords/brain-tumors","display_name":"brain tumors","score":0.453}],"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537,"display_name":"Good health and well-being"}],"institution_awarded":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-07-13T04:17:19.000Z"}